Core Viewpoint - The establishment of a 1 billion yuan investment fund by companies under China Resources, in collaboration with Shanghai Fosun Pharmaceutical and Chengdu state-owned enterprises, aims to focus on the pharmaceutical and health sectors, particularly in innovative drug development and strategic emerging industries [2][4]. Group 1: Fund Structure and Partners - The fund, named China Resources Pharmaceutical (Chengdu) Innovation Investment Fund, has a total capital of 100 million yuan, with various partners contributing different amounts [3]. - The general partner (GP) is China Resources Pharmaceutical (Chengdu) Enterprise Management Partnership (Limited Partnership), while limited partners (LPs) include several pharmaceutical companies and investment funds [2][3]. - The fund's lifespan is set for 7 years, with a 3-year investment period and a 4-year exit period, extendable by 1 year upon partner approval [3]. Group 2: Investment Focus - The fund will concentrate on the pharmaceutical health sector and strategic emerging industries, targeting areas such as chemical innovative drugs, biological drugs (including vaccines), high-end medical devices, and traditional Chinese medicine [4]. - The involvement of the Chengdu Bio-City Jingchuang Equity Investment Fund indicates a strong potential for project implementation within the Chengdu Tianfu International Bio-City [4]. Group 3: Historical Context - An earlier fund, the China Resources Pharmaceutical (Shantou) Industry Investment Fund, was established 8 years ago but did not perform as expected, failing to reach its initial target of 2.5 billion yuan [4][6]. - The Shantou fund entered a liquidation phase in December 2024, having not achieved the anticipated scale, which affected the contributions of its partners [5][6].

Group 1 - The company held its 11th meeting of the 8th Supervisory Board on July 17, 2025, which was conducted via both in-person and remote voting methods [1][2] - The Supervisory Board approved the company's participation in the establishment of the second phase of the China Resources Pharmaceutical Industry Investment Fund, stating that the transaction aligns with the company's overall strategic planning and is fair and reasonable [1][2] - The Supervisory Board concluded that the transaction would not have a significant adverse impact on the company's cash flow or operating performance, nor would it affect the company's independence or harm the interests of the company and its shareholders [1]

Group 1 - China Resources Pharmaceutical (03320.HK) announced the establishment of a joint venture fund named China Resources Pharmaceutical (Chengdu) Innovation Investment Fund Partnership (Limited Partnership) with a proposed scale of RMB 1 billion and a total duration of seven years [1] - The group's proposed capital contribution will be approximately RMB 245 million, accounting for about 24.5% of the total fund capital [1] - The fund is expected to primarily engage in equity investment, venture capital, and investment management activities, focusing on the pharmaceutical and health industry as well as strategic emerging sectors [1] Group 2 - The fund will target investments in areas such as chemical innovative drugs, biological drugs (including vaccines), high-end medical devices (including IVD), traditional Chinese medicine supplements, and synthetic biology, among other strategic emerging fields [1] - The company believes it can leverage the fund's professional investment team resources to effectively control risks associated with mergers and acquisitions and innovation projects, ensuring the quality of target companies and accelerating strategic mergers and acquisitions in the pharmaceutical industry [2] - This strategy aims to enhance the company's long-term sustainable development capabilities within the pharmaceutical sector [2]

证券代码：300294 证券简称：博雅生物 公告编号：2025-052 华润博雅生物制药集团股份有限公司 关于参与设立华润医药产业投资基金二期暨关联交易的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、关联交易概述 为落实华润博雅生物制药集团股份有限公司（以下简称公司或华润博雅生物） 发展战略，有效控制创新项目前期风险，储备优质战略项目资源，提升公司中长 期持续发展与盈利能力，公司于 2025 年 7 月 17 日召开第八届董事会第十四次会 议、第八届监事会第十一次会议，审议通过了《关于参与设立华润医药产业投资 基金二期暨关联交易的议案》，公司拟与普通合伙人华润医药(成都)企业管理合 伙企业(有限合伙)(暂定名，以工商核准名为准)及华润医药投资有限公司等 10 家 有限合伙人共同设立华润医药(成都）创新投资基金合伙企业（有限合伙）(暂定 名，以工商核准名为准，以下简称本基金或该基金)。该基金规模为 10 亿元人民 币，深圳市华润资本股权投资有限公司为该基金管理人。公司拟作为有限合伙人， 以自有资金认缴出资总额 6,000 万元人民币，持有该基金 6%的财产 ...

证券代码：300294 证券简称：博雅生物 公告编号：2025-053 关于申请设备更新改造专项贷款额度的公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 为积极响应国家政策号召，加快推进产业升级，根据《推动大规模设备更新 和消费品以旧换新行动方案》（国发〔2024〕7 号）及财政部、中国人民银行等 部委配套政策，中央财政对符合条件的设备更新贷款提供贴息支持，华润博雅生 物制药集团股份有限公司（简称公司或华润博雅生物）血液制品智能工厂（一期） 建设项目（简称智能工厂项目）符合国家设备更新改造专项贷款政策要求，其中 工艺设备采购支出符合专项贷款支持范围。2025 年 7 月 17 日，公司召开第八届 董事会第十四次会议，审议通过了《关于申请设备更新改造专项贷款额度的议案》， 现拟申请 3.2 亿元设备更新改造专项贷款额度，同步追加调整 2025 年财务预算， 并授权管理层在额度内根据实际需要提款及办理相关手续。具体内容如下： 一、智能工厂项目设备投资概况 智能工厂项目设备预计购置费 9.5 亿元。根据智能工厂项目进度，按已签署 合同总设备投资额剩余未支付金额以及待 ...

第八届监事会第十一次会议决议公告 华润博雅生物制药集团股份有限公司 本公司及监事会全体成员保证公告内容真实，准确和完整，没有虚假记载， 误导性陈述或重大遗漏。 证券代码：300294 证券简称：博雅生物 公告编号：2025-051 关联监事周娇回避表决。 表决结果：2 票同意，0 票反对，0 票弃权。 三、备查文件 1、公司第八届监事会第十一次会议决议。 一、监事会会议召开情况 华润博雅生物制药集团股份有限公司（以下简称公司）第八届监事会第十一 次会议于 2025 年 7 月 12 日以邮件及通讯方式通知，并于 2025 年 7 月 17 日在公 司会议室以现场加通讯表决的方式召开。会议应到表决监事 3 人，实到表决监事 3 人。会议由监事会主席周娇女士主持，公司部分高级管理人员列席会议。本次 会议符合《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》及《公司章程》等相关规定。经充分讨论，审议通过了 以下议案。 二、监事会会议审议情况 1、审议通过《关于参与设立华润医药产业投资基金二期暨关联交易的议 ...

证券代码：300294 证券简称：博雅生物 公告编号：2025-050 华润博雅生物制药集团股份有限公司 第八届董事会第十四次会议决议公告 本公司及董事会全体成员保证公告内容真实、准确和完整，没有虚假记载、 误导性陈述或重大遗漏。 一、董事会会议召开情况 华润博雅生物制药集团股份有限公司（以下简称公司）第八届董事会第十四 次会议于 2025 年 7 月 12 日以邮件及通讯方式通知，并于 2025 年 7 月 17 日在公 司会议室以现场加通讯表决的方式召开。会议应到表决董事 9 人，实到表决董事 9 人。会议由董事长邱凯先生主持，公司监事及高级管理人员列席了会议。本次 会议符合《中华人民共和国公司法》《中华人民共和国证券法》《深圳证券交易 所创业板股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创 业板上市公司规范运作》及《公司章程》等相关规定。经充分讨论，审议通过了 以下议案。 二、董事会会议审议情况 关联董事邱凯、于晓辉、梁小明回避表决。 表决结果：6 票同意，0 票反对，0 票弃权。 2、审议通过《关于申请设备更新改造专项贷款额度的议案》 为积极响应国家政策号召，加快推进产业升级，根据 ...

Core Viewpoint - The training session titled "AI Office Practice" conducted by Dr. Li Jiaying aims to enhance workplace efficiency and innovation through the application of artificial intelligence in office scenarios [1][3]. Group 1: Training Objectives and Content - The training focuses on equipping professionals with skills to utilize AI technologies in document processing, data analysis, intelligent meeting notes, and automated workflow optimization [3]. - Dr. Li Jiaying combines theoretical explanations with practical demonstrations, showcasing how AI tools can expedite tedious office tasks, such as generating reports and organizing data tables [3]. Group 2: Participant Engagement and Impact - Participants actively engaged in the training, expressing that the AI tools' usage techniques would significantly improve their daily work processes [3]. - The training not only enhanced participants' AI office skills but also promoted the broader adoption of AI technology in real-world work environments [3]. Group 3: Future Initiatives - The Unknown AI Research Institute is committed to promoting AI technology and plans to continue offering similar training sessions to support businesses and individuals in achieving efficient office practices and innovative development in the digital age [5].

Core Viewpoint - The article highlights the emergence of Generation Z as a transformative force in technology, exemplified by the AdventureX global hackathon, which showcases their creativity and technical skills [2][4]. Group 1: AdventureX Overview - AdventureX, initiated by two high school students, has grown into a significant innovation platform, attracting nearly 4,500 participants from 182 countries in its inaugural event [5]. - The event has successfully secured over one million yuan in sponsorship and invited top-tier guests from the tech and investment sectors [5]. - This year, AdventureX has expanded its scale and upgraded its venue, drawing even more global talent [5]. Group 2: Significance of Hackathons - Hackathons, like AdventureX, serve as crucial incubators for innovation, where diverse young talents collaborate to develop projects within a limited timeframe [13]. - Many successful products, including Siri and Instagram, originated from hackathons, indicating their importance in the tech ecosystem [13]. - AdventureX has garnered attention from numerous tech companies, providing young developers with broader opportunities [13]. Group 3: Future of Generation Z - AdventureX is positioned as a platform for Generation Z to challenge norms and redefine technological possibilities through their creativity and passion [16]. - The event is expected to unveil innovative projects and highlight the potential of young developers in shaping the future of artificial intelligence [9][16]. - The anticipation surrounding AdventureX reflects the growing recognition of Generation Z's capabilities in the tech industry [17].

Core Viewpoint - The article highlights the emergence of Generation Z as a driving force in technology and innovation, exemplified by the global hackathon AdventureX, initiated by two high school students, which has gained significant attention in the tech community [2][5]. Group 1: AdventureX Overview - AdventureX is one of the largest hackathons globally, attracting young tech enthusiasts from around the world, emphasizing open-source spirit and innovation [2]. - The event was founded by two Generation Z high school students, Zhu Haoyu and Xu Chen, who successfully raised 1 million yuan in sponsorship and invited over 100 prominent figures from the tech and investment sectors [5]. - Last year, AdventureX attracted nearly 4,500 participants from 182 countries and regions, including high school and university students, and has expanded its scale and venue this year [5]. Group 2: Significance of Hackathons - Hackathons, derived from "Hackathon," have become synonymous with technological innovation, where developers, designers, and product managers collaborate to create projects within a limited timeframe [12]. - Many well-known products, such as Siri and Instagram, originated from hackathons, showcasing their role as a breeding ground for innovation [12]. - AdventureX has garnered attention from numerous tech companies, providing a broader platform for young developers and facilitating investment opportunities for promising projects [13]. Group 3: Focus on Generation Z - AdventureX serves as a stage for Generation Z, allowing them to challenge conventions and use creativity to impact the world [15]. - The event is supported by the Unseen Artificial Intelligence Research Institute, which emphasizes the importance of nurturing the younger generation's growth in technology [15]. - The anticipation for AdventureX reflects the belief that these young innovators will contribute significantly to the future of artificial intelligence and technology [15].